lobbying_activities: 2110057
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2110057 | 3afc2859-997f-43e3-8046-cbdcdd6bd078 | Q1 | ERVIN GRAVES STRATEGY GROUP, LLC | 13836 | EMERGENT BIOSOLUTIONS INC. | 2018 | first_quarter | DIS | FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense | Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2018-04-18T12:05:29.627000-04:00 |